These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 7709677)
1. [Effect of vaginal estrogen therapy on urinary incontinence in postmenopause]. Schär G; Köchli OR; Fritz M; Haller U Zentralbl Gynakol; 1995; 117(2):77-80. PubMed ID: 7709677 [TBL] [Abstract][Full Text] [Related]
3. The use of two estrogen preparations (a combined contraceptive pill versus conjugated estrogen cream) intravaginally to treat urogenital symptoms in postmenopausal Thai women: a comparative study. Chompootaweep S; Nunthapisud P; Trivijitsilp P; Sentrakul P; Dusitsin N Clin Pharmacol Ther; 1998 Aug; 64(2):204-10. PubMed ID: 9728901 [TBL] [Abstract][Full Text] [Related]
4. [The effectiveness of intravaginal estriol tablet administration in women with urge incontinence]. Enzelsberger H; Kurz C; Schatten C; Huber J Geburtshilfe Frauenheilkd; 1991 Oct; 51(10):834-8. PubMed ID: 1761173 [TBL] [Abstract][Full Text] [Related]
5. Randomized comparison of tolterodine with vaginal estrogen cream versus tolterodine alone for the treatment of postmenopausal women with overactive bladder syndrome. Tseng LH; Wang AC; Chang YL; Soong YK; Lloyd LK; Ko YJ Neurourol Urodyn; 2009; 28(1):47-51. PubMed ID: 19089890 [TBL] [Abstract][Full Text] [Related]
6. [Treatment of chronic cystitis in postmenopausal women]. Davidov MI; Petruniaev AI; Bunova NE Urologiia; 2009; (4):14-9. PubMed ID: 19824379 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of low-dose intravaginal estriol on urogenital aging in postmenopausal women. Dessole S; Rubattu G; Ambrosini G; Gallo O; Capobianco G; Cherchi PL; Marci R; Cosmi E Menopause; 2004; 11(1):49-56. PubMed ID: 14716182 [TBL] [Abstract][Full Text] [Related]
8. Vaginal estrogen therapy and overactive bladder symptoms in postmenopausal patients after a tension-free vaginal tape procedure: a randomized clinical trial. Zullo MA; Plotti F; Calcagno M; Palaia I; Muzii L; Manci N; Angioli R; Panici PB Menopause; 2005; 12(4):421-7. PubMed ID: 16037757 [TBL] [Abstract][Full Text] [Related]
9. Treatment of urge-predominant mixed urinary incontinence with tolterodine extended release: a randomized, placebo-controlled trial. Khullar V; Hill S; Laval KU; Schiøtz HA; Jonas U; Versi E Urology; 2004 Aug; 64(2):269-74; discussion 274-5. PubMed ID: 15302476 [TBL] [Abstract][Full Text] [Related]
10. [Long-term use of ovestin by postmenopausal women with urinary incontinence]. D'iakov VV; Godunov BN; Gvozdev MIu Urologiia; 2003; (1):43-6. PubMed ID: 12621967 [TBL] [Abstract][Full Text] [Related]
11. [Effect of local estriol therapy on the urethral pressure profile in the postmenopausal period]. Hajdu K; Festge OA; Gross W; Rosenbaum KD Zentralbl Gynakol; 1986; 108(22):1370-8. PubMed ID: 3825332 [TBL] [Abstract][Full Text] [Related]
12. Effect of one-week treatment with vaginal estrogen preparations on serum estrogen levels in postmenopausal women. Labrie F; Cusan L; Gomez JL; Côté I; Bérubé R; Bélanger P; Martel C; Labrie C Menopause; 2009; 16(1):30-6. PubMed ID: 18820592 [TBL] [Abstract][Full Text] [Related]
13. [Gyneco-urologic problems in climacteric]. Enzelsberger H Wien Med Wochenschr; 1992; 142(5-6):115-9. PubMed ID: 1615679 [TBL] [Abstract][Full Text] [Related]
14. [Propiverine hydrochloride improved correlatively subjective QOL and objective findings in Japanese patients with urinary frequency and/or incontinence]. Noguchi K; Yamagishi T; Suzuki K; Kondo K; Kishida T; Saito K; Sekiguchi Y; Nakaigawa N; Ogawa T; Uemura H; Yao M; Kubota Y; Kawai M; Okajima K; Kobayashi K; Moriyama M; Kinoshita Y; Mikata K; Kitami K; Masuda M; Saito R; Murai T; Tomoda T; Noguchi S; Sakai N; Hamano A; Nomura S; Sato K Hinyokika Kiyo; 2006 May; 52(5):343-8. PubMed ID: 16758722 [TBL] [Abstract][Full Text] [Related]
15. [Intravesical administration of estriol in sensory urge incontinence--a prospective study]. Kurz C; Nagele F; Sevelda P; Enzelsberger H Geburtshilfe Frauenheilkd; 1993 Aug; 53(8):535-8. PubMed ID: 8375632 [TBL] [Abstract][Full Text] [Related]
16. Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethra. Smith CP; Nishiguchi J; O'Leary M; Yoshimura N; Chancellor MB Urology; 2005 Jan; 65(1):37-41. PubMed ID: 15667859 [TBL] [Abstract][Full Text] [Related]
17. Comparison of usefulness of estradiol vaginal tablets and estriol vagitories for treatment of vaginal atrophy. Dugal R; Hesla K; Sørdal T; Aase KH; Lilleeidet O; Wickstrøm E Acta Obstet Gynecol Scand; 2000 Apr; 79(4):293-7. PubMed ID: 10746845 [TBL] [Abstract][Full Text] [Related]
18. Effects of ultralow-dose transdermal estradiol on postmenopausal symptoms in women aged 60 to 80 years. Diem S; Grady D; Quan J; Vittinghoff E; Wallace R; Hanes V; Ensrud K Menopause; 2006; 13(1):130-8. PubMed ID: 16607109 [TBL] [Abstract][Full Text] [Related]
19. Predictors of urinary incontinence in a prospective cohort of postmenopausal women. Jackson SL; Scholes D; Boyko EJ; Abraham L; Fihn SD Obstet Gynecol; 2006 Oct; 108(4):855-62. PubMed ID: 17012446 [TBL] [Abstract][Full Text] [Related]
20. Effect of raloxifene on urinary incontinence: a randomized controlled trial. Waetjen LE; Brown JS; Modelska K; Blackwell T; Vittinghoff E; Cummings SR; Obstet Gynecol; 2004 Feb; 103(2):261-6. PubMed ID: 14754693 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]